Depression in patients with coronary artery disease is associated with increased
cardiovascular morbidity and mortality. It is not clear, however, if treatment with selective …

The occurrence of depression in patients with coronary heart disease (CHD) substantially
increases the likelihood of a poorer cardiovascular prognosis. Although antidepressants are …

It has been reported that selective serotonin reuptake inhibitors (SSRIs) might induce major
adverse cardiovascular events (MACE), but the association between the use of SSRIs and …

Depression occurs frequently in patients with coronary heart disease (CHD), and confers
significant risk for additional morbidity and mortality. The cardiac effects of the tricyclic …

The consequences of depression and coronary artery disease (CAD) were reviewed in the
literature. The comorbidity of depression and CAD results in an increased cardiovascular …

Methods. Within 1 week of ACS hospitalization, 457 patients completed the Beck
Depression Inventory and a diagnostic depression interview (see Davidson et al8 for …

Background Depression is an independent risk factor for myocardial infarction (MI).
Selective serotonin reuptake inhibitors (SSRIs) may reduce this risk through attenuation of …

Background: Given the importance of the role of depression in predicting the outcome of
cardiovascular disorders, current medications for treating depression, particularly selective …

Depressive disorders are common in patients with ischemic heart disease and have serious
consequences in terms of the risk of further cardiac events and cardiac mortality. Among …

Depression in patients with acute coronary syndromes (ACS) is common and associated
with impaired cardiovascular prognosis in terms of cardiac mortality and new cardiovascular …